España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
United Therapeutics
UTHR
NASDAQ
Watchlist
Get Report
Perks
Buy
Compare Brokers
$311.04
-6.01
-1.90%
At Close: -
$311.04
0
0.00%
After Hours: 1:46 PM EDT
15 minutes delayed
Get Report
Watch
United Therapeutics (UTHR) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for United Therapeutics (NASDAQ:UTHR) Stock
United Therapeutics Stock (NASDAQ: UTHR)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, June 19, 2024
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Wednesday, June 12, 2024
Deep Dive Into United Therapeutics Stock: Analyst Perspectives (5 Ratings)
Benzinga Insights
Wells Fargo Maintains Overweight on United Th...
Benzinga Newsdesk
Tuesday, June 11, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Monday, June 03, 2024
U.S. District Court For District Of Delaware ...
Benzinga Newsdesk
Tuesday, May 21, 2024
Expert Ratings For United Therapeutics
Benzinga Insights
JP Morgan Maintains Overweight on United Ther...
Benzinga Newsdesk
Thursday, May 09, 2024
Perrigo Q1 Earnings Surpass, Sales Miss Estimates
Zacks
Friday, May 03, 2024
Goldman Sachs Maintains Neutral on United The...
Benzinga Newsdesk
Thursday, May 02, 2024
The Latest Analyst Ratings For United Therapeutics
Benzinga Insights
Oppenheimer Maintains Outperform on United Th...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on United ...
Benzinga Newsdesk
Wednesday, May 01, 2024
Lung Disease-Focused United Therapeutics Says It Is A Compelling Investment Opportunity
Vandana Singh
Powell Industries Posts Upbeat Results, Joins A10 Networks, Garmin, DuPont And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
United Therapeutics shares are trading higher...
Benzinga Newsdesk
United Therapeutics Q1 2024 GAAP EPS $6.17 Be...
Benzinga Newsdesk
Wednesday, April 24, 2024
United Therapeutics Announces Xenothymokidney...
Benzinga Newsdesk
Monday, April 01, 2024
Liquidia Says Judge Andrews Has Set Aside Inj...
Benzinga Newsdesk
Tuesday, March 26, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Monday, March 25, 2024
United Therapeutics shares are trading higher...
Benzinga Newsdesk
United Therapeutics Announces $1B Accelerated...
Benzinga Newsdesk
Tuesday, February 27, 2024
United Therapeutics Filed Motion In U.S. Dist...
Benzinga Newsdesk
Thursday, February 22, 2024
Beyond The Numbers: 4 Analysts Discuss United Therapeutics Stock
Benzinga Insights
Wedbush Reiterates Outperform on United Thera...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on United ...
Benzinga Newsdesk
Wednesday, February 21, 2024
United Therapeutics' Challenges FDA Over Liquidia's Drug Approval Process, Clocks Strong Q4 Earnings
Vandana Singh
United Therapeutics Q4 GAAP EPS $4.36 Beats $...
Benzinga Newsdesk
United Therapeutics Has Commenced Litigation ...
Benzinga Newsdesk
Earnings Scheduled For February 21, 2024
Benzinga Insights
Tuesday, February 20, 2024
Earnings Outlook For United Therapeutics
Benzinga Insights
Monday, February 12, 2024
This United Therapeutics Analyst Is No Longer Bearish, Expects Mid-Decade $4B Revenue Run Rate
Priya Nigam
Teva Pharmaceutical To Rally Around 58%? Here Are 10 Top Analyst Forecasts For Monday
Avi Kapoor
Goldman Sachs Upgrades United Therapeutics to...
Benzinga Newsdesk
Monday, February 05, 2024
Leerink Partners Initiates Coverage On United...
Benzinga Newsdesk
Tuesday, January 23, 2024
Liquidia Said On Jan 22, United Therapeutics Filed A Stipulation To Dismiss All Claims In The New Hatch-Waxman Litigation Related To '793 Paten
Charles Gross
Wednesday, December 20, 2023
Liquidia Says Federal Circuit Affirmed Earlie...
Benzinga Newsdesk
Why Is Pulmonary Hypertension-Focused Liquidia Stock Soaring Today?
Vandana Singh
United Therapeutics shares are trading lower ...
Benzinga Newsdesk
Liquidia Wins Patent Case Against United Ther...
Benzinga Newsdesk
Monday, December 04, 2023
LIVE: Watch U.S. Court Of Appeals For The Fed...
Benzinga Newsdesk
Wednesday, November 29, 2023
As Of November 27, 2023, United Therapeutics ...
Benzinga Newsdesk
Thursday, November 02, 2023
JP Morgan Maintains Overweight on United Ther...
Benzinga Newsdesk
Morgan Stanley Maintains Overweight on United...
Benzinga Newsdesk
Wedbush Maintains Outperform on United Therap...
Benzinga Newsdesk
Wednesday, November 01, 2023
Earnings Scheduled For November 1, 2023
Benzinga Insights
United Therapeutics Q3 EPS $5.38 Beats $5.08 ...
Benzinga Newsdesk
Tuesday, October 31, 2023
United Therapeutics Has Enrolled The First Pa...
Benzinga Newsdesk
Monday, October 30, 2023
Health Care Company United Therapeutics Announces Acquisition of Miromatrix Medical
Benzinga Insights
Why Is Life Sciences Company Miromatrix Medical Stock Trading Higher Today?
Vandana Singh
Why Biophytis Shares Are Trading Higher By Over 12%: Here Are 20 Stocks Moving Premarket
Lisa Levin
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch